Go to deals
Private Equity | Healthcare

AmberStone Group has acquired a stake in Vītola Klīnika and has developed New Hanza Med in Riga

AmberStone Group AS has acquired a 49% stake in Vītola Klīnika and invested in its expansion and relocation to new premises, leading to the creation of New Hanza Med — a modern, multidisciplinary medical and surgical center in the New Hanza district of Riga, Latvia.

Located at Mihaila Tāla iela 1, the new facility brings together specialists from diverse healthcare fields under one roof, providing a full spectrum of services from preventive care to complex surgical procedures. With this project, the group continues to strengthen its position in the healthcare sector, aiming to bring world-class medical standards to Latvia.

AmberStone Group is a Latvia-based investment holding company founded in 2013, specializing in private equity-style investments across sectors including healthcare, hospitality, agriculture, construction, wood processing and renewable energy. The group has extensive experience and a strong track record in developing medical facilities, notably ORTO Clinic.

Vītola Klīnika offers a comprehensive range of gynecological, diagnostic and surgical services delivered by experienced specialists. Patients benefit from advanced technology, effective treatment methods and a personalized approach, ensuring a seamless continuum of care from initial consultation and diagnostics through surgery and post-operative recovery.

Oaklins’ team in Latvia acted as the exclusive buy-side advisor to AmberStone Group, supporting the investment thesis, identifying potential acquisition targets, facilitating introductions and negotiating deal terms.

Parties

Talk to the deal team

Evelīna Valtere

Associate Director
Riga, Latvia
Oaklins Baltics

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more